Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Organ Donor Screening for Carbapenem-resistant Gram-negative Bacteria in Italian Intensive Care Units: the DRIn study.

Procaccio F, Masiero L, Vespasiano F, Grossi PA, Gagliotti C, Pantosti A, Caprio M, Lombardini L, Nanni Costa A; Donor-Recipient Infection (DRIn) Collaborative Study Group.

Am J Transplant. 2019 Aug 10. doi: 10.1111/ajt.15566. [Epub ahead of print]

PMID:
31400257
2.

[Good practices for the surveillance and control of antimicrobial resistance].

Moro ML, Ciofi Degli Atti M, D'Amore C, Diegoli G, Forni S, Gagliotti C, Gemmi F, Iannazzo S, Miraglia V, Pan A, Pantosti A, Pitatlis S, Puro V, Ricchizzi E, Sarnelli B, Torti C, Zotti C.

Epidemiol Prev. 2019 Mar-Jun;43(2-3):185-193. doi: 10.19191/EP19.2-3.P185.058. Italian.

3.

Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017.

Iacchini S, Sabbatucci M, Gagliotti C, Rossolini GM, Moro ML, Iannazzo S, D'Ancona F, Pezzotti P, Pantosti A.

Euro Surveill. 2019 Jan;24(5). doi: 10.2807/1560-7917.ES.2019.24.5.1800159.

4.

Strategies to control antibiotic resistance: results from a survey in Italian children's hospitals.

Ciofi Degli Atti ML, D'Amore C, Gagliotti C, Zotti C, Ricchizzi E, Moro ML, Raponi M; Pediatric antibiotic resistance.

Ann Ig. 2019 Jan-Feb;31(1):3-12. doi: 10.7416/ai.2019.2253.

5.

Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy.

Errico G, Gagliotti C, Monaco M, Masiero L, Gaibani P, Ambretti S, Landini MP, D'Arezzo S, Di Caro A, Parisi SG, Palù G, Vespasiano F, Morsillo F, Moro ML, Procaccio F, Ricci A, Grossi PA, Pantosti A, Nanni Costa A; SInT Collaborative Study Group.

Clin Microbiol Infect. 2019 Feb;25(2):203-209. doi: 10.1016/j.cmi.2018.05.003. Epub 2018 May 22.

PMID:
29800674
6.

Observational pre-post study showed that a quality improvement project reduced paediatric antibiotic prescribing rates in primary care.

Di Mario S, Gagliotti C, Buttazzi R, Cisbani L, Di Girolamo C, Brambilla A, Moro ML; regional working group “Progetto ProBA-Progetto Bambini e Antibiotici-2014”.

Acta Paediatr. 2018 Oct;107(10):1805-1809. doi: 10.1111/apa.14381. Epub 2018 May 25.

PMID:
29723913
7.

Infections in liver and lung transplant recipients: a national prospective cohort.

Gagliotti C, Morsillo F, Moro ML, Masiero L, Procaccio F, Vespasiano F, Pantosti A, Monaco M, Errico G, Ricci A, Grossi P, Nanni Costa A; SInT Collaborative Study Group.

Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):399-407. doi: 10.1007/s10096-018-3183-0. Epub 2018 Jan 29.

PMID:
29380226
8.

Detection of mcr-4 positive Salmonella enterica serovar Typhimurium in clinical isolates of human origin, Italy, October to November 2016.

Carretto E, Brovarone F, Nardini P, Russello G, Barbarini D, Pongolini S, Gagliotti C, Carattoli A, Sarti M.

Euro Surveill. 2018 Jan;23(2). doi: 10.2807/1560-7917.ES.2018.23.2.17-00821.

9.

Influenza A(H7N7) Virus among Poultry Workers, Italy, 2013.

Puzelli S, Rizzo C, Fabiani C, Facchini M, Gaibani P, Landini MP, Gagliotti C, Moro ML, Rangoni R, Piccolomini LL, Finarelli AC, Tamba M, Rezza G, Declich S, Donatelli I, Castrucci MR.

Emerg Infect Dis. 2016 Aug;22(8):1512-3. doi: 10.3201/eid2208.160246. No abstract available.

10.

Streptococcus salivarius by nasal spray for recurrent otitis: how good is the evidence?

Di Mario S, Basevi V, D'Amico R, Gagliotti C, Gangemi M, Marchetti F, Moro ML, Tamburlini G.

Eur J Clin Microbiol Infect Dis. 2016 Jul;35(7):1215-6. doi: 10.1007/s10096-016-2648-2. Epub 2016 May 14. No abstract available.

PMID:
27180246
11.

Prenatal education for congenital toxoplasmosis.

Di Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, D'Amico R, Magrini N.

Cochrane Database Syst Rev. 2015 Oct 23;(10):CD006171. doi: 10.1002/14651858.CD006171.pub4. Review.

PMID:
26493047
12.

A regionwide intervention to promote appropriate antibiotic use in children reversed trends in erythromycin resistance to Streptococcus pyogenes.

Gagliotti C, Buttazzi R, Di Mario S, Morsillo F, Moro ML.

Acta Paediatr. 2015 Sep;104(9):e422-4. doi: 10.1111/apa.13072. Epub 2015 Jun 26. No abstract available.

PMID:
26058421
13.

Control of carbapenemase-producing Klebsiella pneumoniae: a region-wide intervention.

Gagliotti C, Cappelli V, Carretto E, Marchi M, Pan A, Ragni P, Sarti M, Suzzi R, Tura GA, Moro ML; Emilia-Romagna Group for CPE Control.

Euro Surveill. 2014 Oct 30;19(43). pii: 20943.

14.

Risk factors for colonization with carbapenemase-producing Klebsiella pneumoniae in hospital: a matched case-control study.

Gagliotti C, Giordani S, Ciccarese V, Barozzi A, Giovinazzi A, Pietrantonio AM, Moro ML, Pinelli G, Sarti M.

Am J Infect Control. 2014 Sep;42(9):1006-8. doi: 10.1016/j.ajic.2014.05.028.

PMID:
25179335
15.

Hospital statistics for antibiotics: defined versus prescribed daily dose.

Gagliotti C, Ricchizzi E, Buttazzi R, Tumietto F, Resi D, Moro ML.

Infection. 2014 Oct;42(5):869-73. doi: 10.1007/s15010-014-0649-6. Epub 2014 Jun 29.

PMID:
24973982
16.

The Italian national surgical site infection surveillance programme and its positive impact, 2009 to 2011.

Marchi M, Pan A, Gagliotti C, Morsillo F, Parenti M, Resi D, Moro ML; Sorveglianza Nazionale Infezioni in Chirurgia (SNICh) Study Group.

Euro Surveill. 2014 May 29;19(21). pii: 20815.

17.

Feasibility and effectiveness of a low cost campaign on antibiotic prescribing in Italy: community level, controlled, non-randomised trial.

Formoso G, Paltrinieri B, Marata AM, Gagliotti C, Pan A, Moro ML, Capelli O, Magrini N; LOCAAL Study Group.

BMJ. 2013 Sep 12;347:f5391. doi: 10.1136/bmj.f5391.

18.

Antimicrobial stewardship programmes in Emilia-Romagna, Italy.

Pan A, Gagliotti C, Resi D, Moro ML.

J Glob Antimicrob Resist. 2013 Sep;1(3):175-179. doi: 10.1016/j.jgar.2013.05.004. Epub 2013 Jul 15.

PMID:
27873629
19.

Antimicrobial resistance and stewardship in long-term care settings.

Moro ML, Gagliotti C.

Future Microbiol. 2013 Aug;8(8):1011-25. doi: 10.2217/fmb.13.75. Review.

PMID:
23902147
20.

Baby-friendly hospitals and cesarean section rate: a survey of Italian hospitals.

Di Mario S, Cattaneo A, Gagliotti C, Voci C, Basevi V.

Breastfeed Med. 2013 Aug;8(4):388-93. doi: 10.1089/bfm.2012.0157. Epub 2013 Apr 23.

PMID:
23611333
21.

Outbreak of Citrobacter freundii carrying VIM-1 in an Italian Hospital, identified during the carbapenemases screening actions, June 2012.

Gaibani P, Ambretti S, Farruggia P, Bua G, Berlingeri A, Tamburini MV, Cordovana M, Guerra L, Mazzetti M, Roncarati G, Tenace C, Moro ML, Gagliotti C, Landini MP, Sambri V.

Int J Infect Dis. 2013 Sep;17(9):e714-7. doi: 10.1016/j.ijid.2013.02.007. Epub 2013 Mar 23.

22.

Prenatal education for congenital toxoplasmosis.

Di Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, D'Amico R, Magrini N.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD006171. doi: 10.1002/14651858.CD006171.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;(10):CD006171.

PMID:
23450566
23.

Active surveillance for asymptomatic carriers of carbapenemase-producing Klebsiella pneumoniae in a hospital setting.

Gagliotti C, Ciccarese V, Sarti M, Giordani S, Barozzi A, Braglia C, Gallerani C, Gargiulo R, Lenzotti G, Manzi O, Martella D, Moro ML.

J Hosp Infect. 2013 Apr;83(4):330-2. doi: 10.1016/j.jhin.2012.11.024. Epub 2013 Feb 12.

PMID:
23415499
24.

The rise of carbapenem resistance in Europe: just the tip of the iceberg?

Magiorakos AP, Suetens C, Monnet DL, Gagliotti C, Heuer OE; EARS-Net Coordination Group and EARS-Net participants.

Antimicrob Resist Infect Control. 2013 Feb 14;2(1):6. doi: 10.1186/2047-2994-2-6.

25.

Long-term chikungunya infection clinical manifestations after an outbreak in Italy: a prognostic cohort study.

Moro ML, Grilli E, Corvetta A, Silvi G, Angelini R, Mascella F, Miserocchi F, Sambo P, Finarelli AC, Sambri V, Gagliotti C, Massimiliani E, Mattivi A, Pierro AM, Macini P; Study Group “Infezioni da Chikungunya in Emilia-Romagna”.

J Infect. 2012 Aug;65(2):165-72. doi: 10.1016/j.jinf.2012.04.005. Epub 2012 Apr 17.

PMID:
22522292
26.

Staphylococcus aureus in a northern Italian region: phenotypic and molecular characterization.

Gagliotti C, Monaco M, Sabia C, Gargiulo R, Sarti M, Sanchini A, Marchi M, Ambretti S, Calanca F, Carillo C, Cipolloni AP, Confalonieri M, Di Carlo C, Pedna MF, Ricci L, Rossi MR, Incerti SS, Testa G, Venturelli C, Pantosti A, Moro ML.

Scand J Infect Dis. 2012 Jan;44(1):24-8. doi: 10.3109/00365548.2011.603744. Epub 2011 Sep 5.

PMID:
21888564
27.

Secular trends in antibiotic consumption in the adult population in Emilia-Romagna, Italy, 2003-2009.

Pan A, Buttazzi R, Marchi M, Gagliotti C, Resi D, Moro ML; Antibiotic Use and Resistance Surveillance Study Group of Regione Emilia-Romagna.

Clin Microbiol Infect. 2011 Nov;17(11):1698-703. doi: 10.1111/j.1469-0691.2011.03500.x. Epub 2011 May 20.

28.

Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009.

Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, Gür D, Jarlier V, Kahlmeter G, Monen J, Monnet DL, Rossolini GM, Suetens C, Weist K, Heuer O; EARS-Net Participants (Disease Specific Contact Points for AMR).

Euro Surveill. 2011 Mar 17;16(11). pii: 19819. Erratum in: Euro Surveill. 2011;16(14):pii/19834.

29.

Accuracy of automated and manual systems for susceptibility testing of Pseudomonas aeruginosa to piperacillin and piperacillin-tazobactam.

Gagliotti C, Sarti M, Sabia C, Gargiulo R, Rossolini GM, Carillo C, Cassani C, Cipolloni AP, Pedna F, Rossi MR, Incerti SS, Testa G, Venturelli C, Moro ML.

New Microbiol. 2011 Jan;34(1):97-9. Epub 2011 Jan 15.

30.

Knowledge, attitudes and practices survey after an outbreak of chikungunya infections.

Moro ML, Gagliotti C, Silvi G, Angelini R, Sambri V, Rezza G, Massimiliani E, Mattivi A, Grilli E, Finarelli AC, Angelini P, Macini P; Chikungunya Study Group.

Int Health. 2010 Sep;2(3):223-7. doi: 10.1016/j.inhe.2010.07.003.

PMID:
24037703
31.

Chikungunya virus in North-Eastern Italy: a seroprevalence survey.

Moro ML, Gagliotti C, Silvi G, Angelini R, Sambri V, Rezza G, Massimiliani E, Mattivi A, Grilli E, Finarelli AC, Spataro N, Pierro AM, Seyler T, Macini P; Chikungunya Study Group.

Am J Trop Med Hyg. 2010 Mar;82(3):508-11. doi: 10.4269/ajtmh.2010.09-0322.

32.

Why do paediatricians prescribe antibiotics? Results of an Italian regional project.

Moro ML, Marchi M, Gagliotti C, Di Mario S, Resi D; "Progetto Bambini a Antibiotici [ProBA]" Regional Group.

BMC Pediatr. 2009 Nov 6;9:69. doi: 10.1186/1471-2431-9-69.

33.

Comparison of sales and reimbursement data regarding outpatient antibiotic use in a northern Italian Region.

Gagliotti C, Mazzetti I, Moro ML.

Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1115-8. doi: 10.1002/pds.1812.

PMID:
19623576
34.

High prevalence of bla(CTX-M-1)-group extended-spectrum beta-lactamase genes in Enterobacteriaceae isolates from Emilia-Romagna, Italy.

Gagliotti C, Sarti M, Benini F, Cipolloni AP, Venturelli C, Sabia C, Gargiulo R, Moro ML.

J Med Microbiol. 2009 Oct;58(Pt 10):1388-9. doi: 10.1099/jmm.0.008813-0. Epub 2009 Jun 18. No abstract available.

PMID:
19541784
35.

Prenatal education for congenital toxoplasmosis.

Di Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, D'Amico R, Magrini N.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006171. doi: 10.1002/14651858.CD006171.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD006171.

PMID:
19160267
36.

Laboratory detection of extended-spectrum beta-lactamase by an automated system.

Gagliotti C, Sarti M, Benini F, Cipolloni AP, Testa G, Venturelli C, Moro ML.

New Microbiol. 2008 Oct;31(4):561-4.

37.

Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.

Gagliotti C, Buttazzi R, Sforza S, Moro ML; Emilia-Romagna Antibiotic Resistance Study Group.

J Infect. 2008 Sep;57(3):179-84. doi: 10.1016/j.jinf.2008.07.004. Epub 2008 Aug 15.

PMID:
18707763
38.

Re: secular trends in the epidemiology of shingles in Alberta.

Gagliotti C.

Epidemiol Infect. 2008 Apr;136(4):449; author reply 449-50. doi: 10.1017/S0950268807009946. No abstract available.

39.

Emergence of ciprofloxacin resistance in Escherichia coli isolates from outpatient urine samples.

Gagliotti C, Nobilio L, Moro ML; Emilia-Romagna Antibiotic Resistance Study Group.

Clin Microbiol Infect. 2007 Mar;13(3):328-31.

40.

Antibiotic treatments for children ages 0-23 months in a northern Italy region: a cohort study.

Gagliotti C, Morsillo F, Resi D, Milandri M, Moro ML.

Infection. 2006 Jun;34(3):155-7.

PMID:
16804659
41.

Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes.

Gagliotti C, Nobilio L, Milandri M, Moro ML; Emilia-Romagna Antibiotic Resistance Study Group.

Clin Infect Dis. 2006 Apr 15;42(8):1153-6. Epub 2006 Mar 6.

PMID:
16575736
42.

Delay in the treatment of pulmonary TB in a changing demographic scenario.

Gagliotti C, Resi D, Moro ML.

Int J Tuberc Lung Dis. 2006 Mar;10(3):305-9.

PMID:
16562711
43.

[Cholestatic liver disease and thrombocytopenia associated with long exposure to ticlopidine].

Castelnuovo F, Ripamonti D, Gagliotti C, El Hamad I.

Minerva Gastroenterol Dietol. 1998 Dec;44(4):211-4. Italian.

PMID:
16495907
44.

Barriers to effective tuberculosis control: a qualitative study.

Moro ML, Resi D, Lelli B, Nicoli A, Gagliotti C, Falcone F.

Int J Tuberc Lung Dis. 2005 Dec;9(12):1355-60.

PMID:
16466058
45.

A three-year population-based study of antibiotic treatments for children.

Gagliotti C, Morsillo F, Resi D, Milandri M, Moro ML.

Acta Paediatr. 2005 Oct;94(10):1502-4.

PMID:
16299886
46.

Side effects of antituberculosis therapy.

Resi D, Gagliotti C, Moro ML.

Am J Respir Crit Care Med. 2004 Feb 15;169(4):542; author reply 542. No abstract available.

PMID:
14766664
47.

Quality of local guidelines for surgical antimicrobial prophylaxis.

Gagliotti C, Ravaglia F, Resi D, Moro ML.

J Hosp Infect. 2004 Jan;56(1):67-70.

PMID:
14706274

Supplemental Content

Loading ...
Support Center